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  ​  The Insanity Spectrum 
 By Nick Gallagher 
 
On a visit home from college one Spring, I navigated the corridors of a department store 
when a voice came over the intercom. It echoed off the walls and into my eardrum. It was 
calling my name. I looked up at the rafters, paced past each aisle and confirmed my 
suspicion. The voice had not come from anyone. It was a product of my mind. 
 
That hallucination was one of several I experienced as a 19-year-old, which after a month 
of therapy and monitoring, vanished from existence. But the terror of those brief and 
intermittent moments left me with an anxiety that lingered with an impressive persistence. 
I wanted to know what took place in my head — which neurons or chemicals had misfired. 
 
If my hallucinations worsened, I knew I would not be in good hands. Since the late 19th 
century, the mainstream psychiatric community has argued that the neurodegenerative 
nature of severe mental disorders — the idea that those diseases progressively eat away at 
the brain — meant that recovery was out of the question. 
 
People with psychotic disorders make up around a fifth of the homeless population. Those 
with schizophrenia, in particular, have a life expectancy 20 years below the general 
population and around a 5% chance of dying by suicide. There are now more people with 
severe mental illnesses in prisons than in hospitals. Jails in Los Angeles, New York and 
Chicago are among the largest mental health care providers in the country. Meanwhile, the 
average number of psychiatric beds in the U.S. has declined to less than 12 beds per 
100,000 people, far below the 40 to 60 beds recommended by mental health advocates. 
 
Psychosis is defined by a patient’s disconnection from reality. Hallucinations and 
delusions — beliefs that don’t change, even when presented with contradictory evidence 
— are two hallmarks of the illness. But when I learned that 7% of the world’s population 
experience at least one auditory hallucination over the course of their lives and that 
three-quarters of those people never encounter another one, I wanted to figure out what 
separated those transitory experiences from more prolonged bouts of psychosis. 
 
I could also not decipher how far-reaching societal delusions — those linked to QAnon, 
coronavirus vaccines, election fraud and 5G radiation — had managed to accumulate 
millions of believers on the web. Perhaps, the brain regions that had been responsible for 
my internal, personal hallucinations were the same ones that led so many Americans to 
make sense of the world through conspiracy theories. 
 
Schizophrenia, which includes a combination of persistent and overwhelming 
hallucinations and delusions, emerges in men between the ages of 18 and 25. As a 
19-year-old with a family history of mental illness, I begged to fast-forward past the 
threshold of early adulthood to learn my fate: whether I was among the one-time 
voice-hearers, the people with a long-term mental illness or the conspiracy-peddling 
catastrophizers. I came to understand that those distinctions are blurrier than we’d like to 
admit. We are all connected through a shared pathology, falling in some liminal space 
between sanity and madness. 
 
. . . 
 
Six years after my brush with madness, I found myself at Dr. Robert Laitman’s virtual 
support group for the parents of people who live with psychosis. I was among over a dozen 
middle-aged, suburban couples, seated at their kitchen tables or on their front porches. The 
group had previously met each weekend at Laitman’s enormous Westchester County 
home, an hour north of New York City, where they swam in the backyard pool, played 
with the family dog, and took walks around Laitman’s idyllic, forested neighborhood. 
 
The pandemic pushed those get-togethers online and added a new intensity to the 
gatherings. Families from Florida, Arizona, Pennsylvania and Canada logged on to consult 
the group with questions like: What should you do when your child attacks you? How do 
you place a loved one under state-ordered treatment? Should you stop your son or daughter 
from posting about shadows and radio signals on social media? 
 
Laitman, a slight man in his 60s with avian eyes, treats over 100 patients in upstate New 
York. Most have come to him because all of their prior therapy sessions and medicines 
have failed. Originally a nephrologist, Laitman shifted his career when, at the age of 15, 
his son Daniel was diagnosed with schizophrenia. Laitman and his wife, Ann, also a 
doctor, scoured the city for a psychiatrist who would treat Daniel. Most delivered a dire 
prognosis: there was no hope of recovery. Unsatisfied, they buried their heads in piles of 
books and began experimenting on their own, using a careful mix of medications and a 
strict regimen of exercise, therapy and family support. After several months, Daniel got 
better, and Robert and Ann set up their own practice with the same holistic approach that 
had led to their son's recovery. 
 
After years of navigating the mental health industry, the parents at Laitman's support 
group had become experts in the fields of pharmacology, neuroscience and nosology — 
the study of the names clinicians use to classify illnesses. They'd been partnering with their 
kids to concoct a formula that would quiet the voices and visions that so frequently 
exhaust them. The parents had memorized their kids' blood serum levels and their 
metabolic reaction to various medicines. I was never prescribed an antipsychotic 
medication during my month-long episode, but even today, I would consume anything that 
promised to prevent my hallucinations from bubbling up again. Perhaps, these families had 
unearthed some new drug or experimental treatment that might help me outrun a more 
permanent slide into delirium. I was willing to try anything. 
 
. . . 
 
For millennia, humans have attempted to control the unwieldy brain, often at a great cost 
to their own physical health. In 2016, archeologists in Sudan unearthed a skull dating back 
to the Neolithic period that had a peculiar man-made puncture on its crest. The specimen 
was among thousands of skeletons, discovered from South America to Polynesia, that 
exhibit similarly carved holes. Ancient cultures enlisted shamans and witches to drill into 
the skull to release demons and evil spirits, and in the process, many possessed patients 
died. Swindlers roaming the European countryside​ ​revived the practice in the Middle 
Ages, promising to extract a “stone of madness” entombed in the heads of psychotic 
people. 
 
In the first half of the 20th century, psychologists tried more sophisticated techniques: 
inducing seizures with stimulants, snipping parts of the pre-frontal cortex or placing sick 
people in insulin comas to rid them of psychosis. Then, in the 1950s, they settled on a new 
class of drugs that targeted dopamine and serotonin receptors in the brain to quell 
hallucinations and delusions. These antipsychotic medications became the de-facto 
treatment for people with severe mental illness. 
 
The pharmaceutical industry saw that people with psychotic disorders represented a 
lucrative, untapped demographic. The industry now brings in nearly $12 billion annually. 
But like the snake oil salesmen before them, drug companies have sometimes oversold 
their products. One recent commercial for a medication called Fanapt features two 
immaculately dressed women on their way to an art show. They reminisce about their 
seemingly instantaneous recovery from psychosis — now a far-off memory, thanks to their 
prescription. Fanapt, manufactured by the Washington, D.C.-based Vanda 
Pharmaceuticals, will generate $85-95 million in sales this year. It is no more effective 
than the several dozen other antipsychotics currently on the market. 
 
Around a third of people with psychosis do not respond to antipsychotic medications at all, 
and those who do often contend with debilitating side effects ranging from body tremors 
and​ ​weight gain to insulin instability and heart inflammation. Clozapine, the antipsychotic 
that outperforms all others in clinical trials, was first synthesized over 60 years ago. No 
worthy replacement has emerged since then. 
 
Modern-day antipsychotics like clozapine disinhibit dopamine and serotonin receptors, but 
Dr. Joshua Kantrowitz, director of the Schizophrenia Research Center at Columbia 
University, said psychosis likely arises from interactions between multiple receptors, many 
of which have not been isolated yet. 
 
“It’s 100 different illnesses with 100 different causes,” Kantrowitz said. 
 
Receptors that regulate muscarine and glutamate and trace-amines could all play a role. 
There are other unknown mechanisms that neurologists like Kantrowitz are still working to 
isolate, like hunting for some strange creature in the deep black ocean. They've identified 
seemingly unrelated risk factors: growing up in a city, consuming cannabis at an early age, 
undetectable birth complications, a damaged region of the brain or an unlucky set of genes. 
But Kantrowitz said the medical community has yet to understand how those components 
fit together to create psychosis. 
 
“So you may find a drug that acts as a blunt instrument for most patients," Kantrowitz 
said. "That doesn’t mean we’re treating the root cause.” 
 
Dr. E. Fuller Torrey, a psychiatrist whose Stanley Medical Research Institute at one time 
funded around a quarter of schizophrenia research in the U.S., thought he'd stumbled upon 
a breakthrough while studying an infection that originates in house cats called Toxoplasma 
gondii. The Centers for Disease Control and Prevention estimates that around 11% of 
Americans are infected with the pathogen while other nations may have rates as high as 
60%. 
 
Rats infected with T. gondii are more likely to behave carelessly around predators, which 
helps the pathogen spread into new hosts. Humans with the infection may exhibit similar 
behavioral changes that make them more willing to take risks, with one study 
demonstrating a “2.65 times increased risk to be involved in a traffic accident relative to 
the general population.” The infection may lead to subtle, undetectable shifts in a person’s 
behavior — a hot temper or a propensity for anxiety. For Torrey, it’s not a stretch, then, to 
study T. gondii’s long-term effects on the brain and explore whether it may, in rare 
instances, ignite psychotic symptoms. 
 
Perhaps I had been the victim of some yet unknown virus or pathogen. It was, in an odd 
way, a hopeful prospect. If all the world's psychoses are caused by bacteria or viruses, we 
might be made permanently sane with a single antibiotic or a vaccine. 
 
But Torrey's theory remains a fringe idea, with the majority of psychiatrists unconvinced 
that pathogens account for most schizophrenia cases. 
 
“Sometimes these unusual situations turn out to be true, but what makes them unusual is 
that they’re really rare,” said Kantrowitz. “A lot of people don’t want to accept, for 
obvious reasons, that their son or daughter who grew up relatively normal is not that 
person anymore.” 
 
. . . 
 
The voice first visited on my way to class one morning in the verdant mountain town 
where I attended college. I crossed a field surrounding my classroom and heard him. 
 
“Hey, Nick. Hey, Nick,” he whispered. “Jump off the building.” 
 
My eyes settled on the roof. I saw no way to reach the top, so I was safe for now. There 
were other muffled whispers in the background that I couldn't make out. I thought of 
atoms — my body as the nucleus with a fog of electrons, the voices, spinning around and 
around. Somehow, I knew that this would happen to me. I'd waited my entire life to be 
touched with madness, like my father and grandmother before me. They suffered from 
bipolar disorder and depression. It was in my blood, lying dormant, waiting for the right 
time to reveal itself. 
 
In class, I steadied my shaky hands on a computer keyboard and tried to focus on an online 
quiz when clattering machinery and more indistinct voices, like the din of a busy office 
building, emerged from my skull. I turned toward my classmates and saw the blue digital 
light of their computer screens flickering onto their faces. I had a desperate thought that 
maybe they, too, had heard the sounds: ambient chatter, now growing more distant, like 
the low hum of an airport lounge. They kept clicking. No, my classmates were oblivious to 
the internal world that had sprung up in my head, and I was alone. 
 
When I visited a school counselor the next morning, she told me to get some rest and sent 
me on my way with no further instructions. It was probably a one-time thing, she’d said. 
But later that week, the hallucinations continued. Voices beckoned as I ascended a steep, 
crooked staircase that led to my dorm one afternoon. "Nick, Nick," they whispered. At 
night, I'd been chatting with friends outside when I saw a shadow dash behind a dumpster. 
I peeled away to follow its trail, but saw only the glow of streetlights and cars circling a 
roundabout in the distance. 
 
That weekend, I took the three-hour trip to my parents’ house. I wanted a second opinion 
about my condition, but with such late notice, there were no private practices that could 
take me on as a patient. So I drove with my mom to an urgent care center for mental health 
emergencies. The office was inside a decaying brick building shrouded in scaffolding. For 
four hours, we shuffled through a series of identical waiting rooms lit by harsh fluorescent 
lights and dotted with off-center abstract paintings. I squirmed in my seat, reciting my 
symptoms in my head. In each room, I'd find a new group of despondent patients, staring 
into the corners of walls, waiting, as if trapped in a kind of purgatory. I waited with them. 
 
When I finally met the doctor, I rambled off my symptoms, stream-of-consciousness style. 
I knew I'd have only a few minutes to convince her of my impending madness and only a 
few days before I'd need to return to school. The voices were hard to track, I told her. They 
came at night as I tossed and turned in bed. The wind sounded like whispers. The whir of 
the air conditioning held secrets. I could not predict when the next ones would haunt me. I 
worried that people were following me, or was I so anxious that I had willed that delusion 
into existence? 
 
I left with only a prescription for a mild antidepressant and a recommended reading — a 
cheesy self-help book called “Don’t Sweat the Small Stuff.” And I knew then, this was 
only going to get worse. 
 
. . . 
 
Back at Laitman’s group, the discussion shifted to diagnosis, and I listened for clues to 
help me decipher the parameters of my own hallucinatory episode. If scientists hadn’t yet 
found a cure, perhaps I’d be secure in at least having a name to attach to what I’d been 
through. 
 
One mom rattled off her son’s latest diagnosis, which he’d received on a recent visit to a 
psychiatrist. This was the third time it had changed, she said, and he was back to the one 
doctors gave him the first time. 
 
“Schizoaffective, bipolar type, with psychosis,” the mother recited. 
 
Laitman smiled. “Oh, there you go. I love that. With a dash of salt!” 
 
He finds the naming conventions for psychotic disorders arbitrary and prefers a catch-all 
term — psychotic spectrum disorder — which accounts for the hundreds of ways 
symptoms can manifest in any particular patient. 
 
This mindset makes sense to Dr. Pamela DeRosse, a behavioral psychologist at the Zucker 
School of Medicine in New York. DeRosse conducts interviews with two types of people: 
those with psychotic disorders and those without. It's sometimes difficult to tell the two 
groups apart. During one session, she observed a father and son who had no anxiety, no 
stress and no depression and yet insisted that a ghost had been haunting them. Another 
subject lived an ordinary life but believed wholeheartedly that he was Napoleon Bonaparte 
reincarnated. DeRosse became fascinated by the fuzzy, in-between state — half-sane and 
half-mad — that these interviewees occupied. Some psychiatrists might take their 
idiosyncratic beliefs as warning signs of a burgeoning mental illness, but DeRosse says 
that in many cases, these anomalies are harmless parts of human perception. 
 
"The only boundary that exists is the distress and the impairment associated with those 
experiences," DeRosse said. 
 
She has come to believe that psychosis exists on something of a continuum. People who 
have a single, fleeting hallucinatory experience occupy one side of the spectrum. The other 
is composed of people whose hallucinations and delusions are so immersive and 
all-encompassing that it becomes difficult to distinguish them from real life. 
 
In the psychiatric community, this once controversial idea, known as schizotypy, is 
gaining traction, especially as new evidence reveals that psychotic experiences are 
common, even in otherwise healthy individuals. Around 13% of children and 12% of teens 
across the world report hearing auditory hallucinations, with a smaller portion of adults 
admitting to such experiences, according to one recent meta-study. These sorts of 
transitory experiences can be caused by a fever, a brain tumor or overwhelming stress. But 
DeRosse thinks psychotic symptoms could also be a normal part of early development — 
something a great deal of us experience as young children and subsequently forget or 





1893:​ German psychiatrist and eugenicist Emil Kraepelin defined dementia praecox
(premature dementia) as a brain disease. He believed that the disorder progresses
over the course of a patient's life as her cognitive functions begin to separate. His
views influenced psychology into the 20th century. 
 
1908:​ Swiss psychiatrist Eugen Bleuler coined the term "Group of Schizophrenias,"
recognizing that a great variety of symptoms may arise in people with psychosis.
Unlike Kraepelin, he believed that recovery was possible for a great number of
patients. But, like his predecessor, he continued to advocate for eugenics. 
 
1997:​ British academic Gordon Claridge released "Schizotypy: Implications for
Illness and Health." The book argued that psychosis lies on a continuum and that
hallucinations and delusions are a normal part of the human experience. He also  
explored potential benefits of psychotic experiences, including their potential to
enhance creativity and empathy.  
 
Others like Jim van Os, a psychiatrist and epidemiologist at the University of Utrecht, hold 
an even broader view of what constitutes psychosis. If someone watches a frightening 
horror movie and then goes on a walk through the woods at night, she may see shadows 
darting between trees or misinterpret rustling leaves as a stalker's footsteps. This is a mild 
psychotic experience, according to van Os, and it is not wholly different from the more 
severe bouts of psychosis that people with schizophrenia face. 
 
The Diagnostic and Statistical Manual of Mental Disorders, used by psychiatrists in the 
U.S. to diagnose mental illnesses, had previously designated strict subtypes of 
schizophrenia. But in the latest edition, those categories have been removed and replaced 
with a more open-ended definition of psychosis, to reflect studies that show its wide 
spectrum of possible symptoms. The manual also includes a section for unspecified or 
transient psychotic experiences, like those encountered by large swaths of the general 
population. 
 
In the Western world, hallucinations are a taboo subject, unless we’re discussing “Moses 
and his burning bush, Paul on the road to Damascus, Arjuna’s vision of Krishna, [or] 
Buddha beneath the Bo tree,” as one recent study on international voice-hearing put it. The 
sizable fraction of people who report at least one auditory hallucination over the course of 
their lives often stay silent about the experience, unless they’re explaining it through a 
supernatural or religious lens — a message from God or a ghost’s omen. 
 
But as much as we'd like to ignore it, the history of humanity is also the history of 
madness. Early psychotic episodes may have played a role in human development, 
according to Julian Jaynes, a psychologist at Princeton University. In 1977, Jaynes alleged 
that psychosis was once the default state of the human mind and that hallucinations may 
have given rise to consciousness, to Gods and demons and to civilization. Before early 
humans were capable of coming up with their own internal thoughts, Jaynes argued, they 
may have received a constant stream of auditory hallucinations that guided them and 
taught them how to survive. Jaynes acknowledged that more research would be necessary 
to put his theories to the test, but even skeptics admit that his ideas raise questions about 
the role that hallucinations and delusions once played in early human development. 
 
That doesn't make the horror of modern-day psychotic experiences any less disturbing for 
sufferers who occupy the severe side of the schizotypy continuum. We can dismantle the 
entire idea of mental illness, but that can't silence the voices. 
 
. . . 
 
Back on campus, I sat on one side of a sparsely-seated dining hall — a long, narrow 
stretch of tables and booths with windows that looked out onto a stagnant pond. On the 
other side of the corridor, a student whom I’d never seen before lifted her head from her 
plate, smiled and waved to me. I waved back. Then I began to question whether she had 
waved at all and realized that I must have imagined the entire scenario. I had read about 
this before: a delusion of grandiosity, the false belief that every action in the world is 
somehow related to one's own existence. I got up from the table, threw away my lunch and 
prepared for my descent into a world of psychosis. 
 
By some bit of dumb luck, that never happened. As the weeks passed, I experienced a few 
more hallucinations, but their messages were tamer, mostly just my name now, as if they'd 
gotten bored of me and had moved on to some new, wide-eyed victim. Soon, the 
hallucinations were gone entirely. I had spent my time worrying about some uncertain 
future while others faced a more immediate threat, living with ghosts and demons, and not 
metaphorical ones. That didn't stop me from obsessively wading around the internet to 
uncover some final explanation for what occurred in my mind. 
 
The parents at Laitman's group had abandoned that search long ago, recognizing they 
might never learn the answer. Instead, they concerned themselves with what was in front 
of them, here in the tangible universe. One mom rejoiced when she watched her kid pick 
up a novel from a used bookstore and read it all, cover-to-cover, in one night. A father 
found hope in a hike with his son. Others were proud of their child's college admission 
essay or determination to arrive on-time for a weekend shift at the drugstore. Then, 
someone raised a concern that his son had waited until the last minute to do his homework. 
He wanted to know if that was part of the illness. The group debated for a while and then 
had a good laugh, remembering that they all were awful procrastinators themselves. 
 
During the final meeting I attended, Laitman described psychosis as a “slow-moving 
stroke.” It’s well-established, he said, that long-time sufferers display a loss of gray matter 
after enduring years of hallucinations and delusions. At that moment, I recalled the fog of 
voices I’d experienced as a 19-year-old. I could almost hear them again — their angry 
tenor and persistence — and I feared that the madness might one day return, springing 
forth out of nowhere, just as it had come. 
 
The parents logged off, now seated alone on their couches or screened-in porches, 
reviewing the notes they’d scrawled throughout the meeting — new medicines to try, new 
groups to join, new studies to scrutinize. They’d wait one week before returning again to 
this sanctuary. At around that time, their sons and daughters crawled out of bed, rubbed 
their eyes, got dressed, brushed their teeth and prepared for the 2:00 p.m. session. At the 
meeting, their minds must have wandered to the day they’d return to the Laitman 
household and run and swim, and, toward the end of the evening, sit down for dinner. 
 
. . . 
 
"The Insanity Spectrum" is a capstone project by Nick Gallagher, a Master's candidate at 
the Craig Newmark Graduate School of Journalism at CUNY. 
 
